Main
>
ONCOLOGY (**)
>
Lung>SCLC>MET
>
Treatment
>
USA. G. AtezolizuMAb+
USA. G. AtezolizuMAb+'s subsections
(*) USA Approval Date: 2019. 03.18
+>Carboplatin+Etoposide (ChemoThera
1st Line Treat.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2019. 03.19.
TradeMark
TradeMark Web-Site
USA. G. AtezolizuMAb+'s products
This section has no products
(*) USA Approval Date: 2019. 03.18
+>Carboplatin+Etoposide (ChemoThera
1st Line Treat.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2019. 03.19.
TradeMark
TradeMark Web-Site